NYBC Ventures — Full Portfolio

Akadeum manufactures GMP-compliant ancillary materials for cell and gene therapy applications, specializing in microbubble-based negative selection products.

Advanced ManufacturingBiotechDeep TechHealthtechMedical DevicesAnn Arbor, US

Kalyan Handique(Executive Officer, Director)JYJohn Younger(Executive Officer, Director)inJames Militello(Executive Officer)

BoardJeffrey S. Williams(Director)PDPaul D'Amato(Director)inDKDan Kidle(Director)in

Co-investorsARArboretum VenturesBEBeringeaBEBerkeley CatalystBLBlueStone Venture PartnersCACANTILEVER INVESTORSELeLab Ventures+7 more

Aronora is a clinical-stage biotech developing antithrombotic therapies, including factor XI/XIa inhibitors and thrombolytic drug candidates, to treat and manage thrombotic and thromboembolic conditions such as acute ischemic stroke, heart attack, and pulmonary embolism.

BiotechDeep TechHealthtechPortland, US

EIErik I. Tucker(President & Chief Executive Officer)in

AvenCell Therapeutics develops next-generation cell therapies for hard-to-treat cancers, including solid tumors, combining switchable universal CAR-T technology with a CRISPR/Cas9-based allogeneic platform.

BiotechLongevityMedical Devices

ASAndrew Schiermeier(Chief Executive Officer)in

Co-investorsNONovo HoldingsBLBlackstone Life SciencesEIEight Roads VenturesF-F-Prime Capital

CatenaBio develops precision conjugation technology using native amino acids to enable biotherapeutic fusions of small molecules, nucleic acids, enzymes, and cells.

BiotechDeep TechHealthtechMedical DevicesBerkeley, US

MLMarco Lobba(Founder)inMatthew Francis(Founder)inMLMarco Lobba, Ph.D.(Founder)in

Co-investorsCACALIFORNIA INNOVATIONCICivilization Ventures Management, LlcCRCreative Destruction Lab (CDL)FRFREEFLOWIAIaso VenturesLOLongeVC+5 more

Cellular Origins provides automated cell therapy manufacturing solutions through its Constellation platform, which integrates robotics and digital management to enable GMP-compliant scaling of cell therapies with minimal process modification.

Advanced ManufacturingBiotechRoboticsCambridge, GB

Co-investorsHIHighland EuropeTTTTP VenturesJOJohnson & Johnson Innovation – JJDC

City Therapeutics develops RNAi-based medicines targeting rare, specialty, and prevalent diseases using engineered trigger molecules and precision delivery ligands.

BiotechMedical DevicesCambridge, US

MKMark Keating, MD(Co-founder)KNKotaro Nakanishi, PhD(Co-founder)YTYukihide Tomari, PhD(Co-founder)PZPhillip Zamore, PhD(Co-founder)Andy Orth(Chief Executive Officer)

Co-investorsANAN Venture PartnersARARCH Venture PartnersSOSofinnova VenturesCACasdin CapitalFIFidelity InvestmentsINInvus+2 more

A blood bank and laboratory services provider supplying blood products including red blood cells, plasma, and platelets to hospitals and medical facilities, alongside laboratory testing services and specialty clinical procedures.

BiotechHealthtechMedical DevicesNew York, US

Functional Fluidics is a CLIA-certified diagnostic lab offering proprietary red blood cell function biomarker assays, starting with Sickle Cell Disease.

BiotechDigital HealthHealthtechMedical DevicesDetroit, US

PHPatrick Hines(CEO & Founder)inDr. Hines(Founder)JCJohn Cunningham(Chief Operating Officer)in

Co-investorsIDID VenturesMIMichigan RiseREResilient VenturesSESeae VenturesWAWavemaker Three-Sixty Health

A healthcare-focused investment firm managing approximately $2 billion in assets across 52 portfolio companies.

Digital HealthHealthtechMedical Devices

Co-investorsUNUnion Grove Venture Partners

Immusoft develops a cell therapy platform called Immune System Programming (ISP) that engineers a patient's B cells into plasma cells that produce therapeutic proteins after being infused back into the patient.

BiotechDeep TechHealthtechSeattle, US

MSMatthew Scholz(Founder)inSASean Ainsworth(Chief Executive Officer)inRSRobert Sikorski(Chief Medical Officer)RHRob Hayes(Chief Scientific Officer)inSMScott McIvor(Chief Development Officer)Eric Garcia(Executive Officer)in

Co-investorsBIBioRock VenturesBOBoston Harbor AngelsBRBreakout VenturesEQEQx FundINInvariantes FundMIMichigan Capital Network+4 more

KaloCyte develops ErythroMer, a dried, shelf-stable artificial red blood cell for use in emergency and trauma care when stored blood is unavailable or in short supply.

BiotechDeep TechHealthtechMedical DevicesBaltimore, US

ADAllan Doctor(Co-Founder & CSO)inDPDipanjan Pan(Co-Founder, Chief Technical Officer)inPSPhilip Spinella(Co-Founder, Chief Medical Officer)inDaniel Getman(Director)Gregory Lanza(Director)

Co-investorsBIBioAdvanceBIBioGenerator VenturesDEDelaware Crossing Investor GroupMAMaryland TEDCOOLOld Line Capital PartnersTETEDCO

Star Therapeutics develops treatments aimed at addressing real-world patient needs.

BiotechSouth San Francisco, US

ARAdam Rosenthal(Founder & CEO)inNancy Stagliano(Director)inMichelle Carpenter(Executive Officer)Sandip Panicker(Executive Officer)SRScott Robertson(Executive Officer)inGary Patou(Executive Officer)in

Co-investorsFRFrazier Life SciencesOROrbiMedRARA CapitalSASanofi VenturesSOSofinnova VenturesAGAgent Capital+10 more

Thymmune Therapeutics develops a machine learning-driven thymic cell engineering platform that mass-produces iPSC-derived thymic cells to restore immune function affected by aging and disease.

AI & Machine LearningBiotechLongevityCambridge, US

SWStan Wang(MD, PhD)inBLBing Lim(MD, PhD)inMJManish Jainin

Co-investorsPIPillar VC

Vitestro is a Netherlands-based medical robotics company that develops Aletta, an autonomous robotic phlebotomy device for diagnostic blood collection in hospitals and laboratories.

HealthtechMedical DevicesRoboticsNetherlands, NL

TOToon Overbeeke(Co-founder & CEO)inBJBrian Joseph(Co-founder)in

Co-investorsSOSonder CapitalINIntervestINInvest-NLMAMayo Clinic Ventures